AIVIVO LTD

🏛️Establishedactive
10694447 · ltd · incorporated 2017-03-28
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2026
Net worth
book net assets
Opportunity
76/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
ALSO REGISTERED FOR
  • 74909Other professional, scientific and technical activities n.e.c.
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 2 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
2 connected companies via shared directors
51
Filing history
33 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
76/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Mar 2025Mar 2026

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2026-03-312025-03-31

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

3 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
1
filing
  • 1 accounts
Last 90 days
7
filings
  • 4 officers
  • 1 accounts
  • 1 confirmation-statement
Last 180 days
7
filings
  • 4 officers
  • 1 accounts
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (22 events)Click to expand
  1. 2026-06-08
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2026-04-28
    📄
    replacement-filing-of-director-appointment-with-name
    officers · RP01AP01
  3. 2026-04-14
    📄
    change-person-director-company-with-change-date
    officers · CH01
  4. 2026-04-12
    📄
    change-person-director-company-with-change-date
    officers · CH01
  5. 2026-04-11
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  6. 2026-04-09
    📄
    change-person-director-company-with-change-date
    officers · CH01
  7. 2025-11-03
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  8. 2025-06-10
    📄
    change-person-director-company-with-change-date
    officers · CH01
  9. 2025-03-27
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  10. 2024-04-08
    📄
    change-person-director-company-with-change-date
    officers · CH01
  11. 2024-04-08
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  12. 2024-03-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2023-03-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  14. 2021-12-24
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2021-03-26
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  16. 2020-08-21
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  17. 2020-07-14
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  18. 2020-06-19
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  19. 2019-10-29
    SHAHIDI, Mehdi, Dr appointed
    director
  20. 2019-10-10
    CLEEVELY, Matthew Gregory Richard appointed
    director
  21. 2017-03-28
    🏢
    Company incorporated
    As AIVIVO LTD
  22. 2017-03-28
    GIFANI, Peyman, Dr appointed
    director

Owner dependency

58/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +Senior director age: Director aged approximately 61 — approaching natural succession window.

Succession & seller-readiness

40/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 61. Early succession window.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Dr Peyman Gifani
Individual · British · DOB 09/1980 · age 46
75100%
75–100%board control75-100% shares · 75-100% voting · board control28/03/2017

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · CB postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
AELORA LIMITED
16696506 · est 2025 · no financials extracted
AGFEC CONSULTING LTD
13753335 · est 2021 · no financials extracted
4y
AGNOTIS CARE PRODUCTS CO., LTD
12461826 · est 2020 · no financials extracted
6y
AGRETHOS LTD
12493090 · est 2020 · no financials extracted
6y
AGUILA RISK SERVICES LIMITED
16457351 · est 2025 · no financials extracted
AH ASSET MANAGEMENT LIMITED
15405228 · est 2024 · no financials extracted
2y
AI & HUMAN EMPOWERMENT CIC
16836393 · est 2025 · no financials extracted
AIMAX AXIS LIMITED
16937969 · est 2025 · no financials extracted
AIRCRAFT MANAGEMENT SERVICES LTD
07719505 · est 2011 · no financials extracted
14y
AJB FIDELIS GROUP LTD
12247540 · est 2019 · no financials extracted
6y
AJC ACCOUNTING LTD
07221283 · est 2010 · no financials extracted
16y
AJIIL HUMAN CAPITAL LTD
11999518 · est 2019 · no financials extracted
6y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2017-03-28
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

25 Bioinnovation Centre
Cambridge Science Park, Milton
Cambridge
England
CB4 0FW
United Kingdom

Filing status

Accounts
Next due: 2027-12-31
Last made up to: 2026-03-31
Confirmation statement
Next due: 2027-04-10
Last: 2026-03-27

Officers (3 active · 0 resigned)

CLEEVELY, Matthew Gregory Richard
director · ~42y · appointed 2019-10-10
View their other companies + combined net worth →
Active
GIFANI, Peyman, Dr
director · ~46y · appointed 2017-03-28
View their other companies + combined net worth →
Active
SHAHIDI, Mehdi, Dr
director · ~61y · appointed 2019-10-29
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (33 total)

accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-06-08
confirmation-statement-with-updates
confirmation-statement · CS01
2026-04-28
replacement-filing-of-director-appointment-with-name
officers · RP01AP01
2026-04-28
change-person-director-company-with-change-date
officers · CH01
2026-04-14
change-person-director-company-with-change-date
officers · CH01
2026-04-12
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2026-04-11
change-person-director-company-with-change-date
officers · CH01
2026-04-09
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-11-03
change-person-director-company-with-change-date
officers · CH01
2025-06-10
confirmation-statement-with-updates
confirmation-statement · CS01
2025-03-27
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-03-27
confirmation-statement-with-updates
confirmation-statement · CS01
2024-04-08
change-person-director-company-with-change-date
officers · CH01
2024-04-08
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-04-08
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-03-28